Harvest Group Wealth Management, LLC Galapagos Nv Transaction History

Harvest Group Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$76.15 - $111.94 $14,011 - $20,596	-184 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$185.52 - $231.25 $5,565 - $6,937	30 Added 19.48%	184 $36,000
Q2 2019 Jul 31, 2019	BUY	$111.45 - $128.93 $1,894 - $2,191	17 Added 12.41%	154 $19,000
Q1 2019 May 06, 2019	BUY	$89.61 - $117.78 $12,276 - $16,135	137 New	137 $16,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.